Tuesday, August 9, 2016

BRIEF-Valeant seeking to modify lender agreements - CEO

Aug 9 (Reuters) - Valeant Pharmaceuticals comments from

slide presentation and conference call:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)